US reference laboratory completes ASTar® evaluation
US reference laboratory completes ASTar® evaluation
Q-linea AB (publ) (OMX:QLINEA) today announces that a US reference laboratory has completed their analytical evaluation of the ASTar instrument and Gram-negative blood culture panel.
The company is now in discussions with the reference laboratory leadership regarding next steps for implementation of ASTar for routine clinical use. Additional evaluations are ongoing at several US academic medical centers.
Interest in adoption and implementation of the ASTar system continues to grow due to the fully automated nature of the instrument, low hands-on time, high throughput, and ease of use.
Previous communication (May 2nd): https://qlinea.com/mfn_news/q-linea-signs-evaluation-contract-with-reference-laboratory-network-in-the-us/?ln=en